Guardant Health to Participate in Upcoming June Investor Conferences
May 20 2021 - 8:05AM
Business Wire
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
company, today announced the company will be participating
virtually in the following investor conferences.
- William Blair 41st Annual Growth Stock Conference Fireside Chat
on Tuesday, June 1st at 12:00 p.m. Pacific Time / 3:00 p.m. Eastern
Time
- Goldman Sachs 42nd Annual Global Healthcare Conference Fireside
Chat on Tuesday, June 8th at 12:00 p.m. Pacific Time / 3:00 p.m.
Eastern Time
Interested parties may access a live and archived webcast of the
presentation on the “Investors” section of the company website at:
www.guardanthealth.com.
About Guardant Health
Guardant Health is a leading precision oncology company focused
on helping conquer cancer globally through use of its proprietary
blood tests, vast data sets, and advanced analytics. The Guardant
Health oncology platform leverages capabilities to drive commercial
adoption, improve patient clinical outcomes, and lower healthcare
costs across all stages of the cancer care continuum. Guardant
Health has commercially launched liquid biopsy-based Guardant360®,
Guardant360 CDx, and GuardantOMNI® tests for advanced stage cancer
patients, and Guardant Reveal™ test for early-stage cancer
patients. These tests fuel development of its LUNAR screening
program, which aims to address the needs of asymptomatic
individuals eligible for cancer screening.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210520005163/en/
Investor Contact: Carrie Mendivil
investors@guardanthealth.com Media Contact: Anna Czene
press@guardanthealth.com Julie Johnson
julie.johnson@uncappedcommunications.com
Guardant Health (NASDAQ:GH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Guardant Health (NASDAQ:GH)
Historical Stock Chart
From Apr 2023 to Apr 2024